Progenics Stem Cell Cryobank

Progenics Stem Cell Cryobank is a pioneering company based in Toronto, Ontario, Canada with a mission to harness the potential of cord blood and cord tissue for regenerative medicine. The company boasts state-of-the-art facilities and cutting-edge processing techniques, achieving an exceptional average of 95 ± 3% of total nucleated cells, surpassing industry standards.

Their commitment to transparency is evident through readily accessible yearly quality reports on their website. Progenics also guarantees quality and reliability, offering to waive the processing fee if samples yield less than 85% of total nucleated cells. With accreditation by AABB, Health Canada, and the FDA, Progenics reflects an unwavering dedication to excellence, ensuring the utmost safety of secured long-term storage of precious stem cells in Markham, Ontario.

Established in 2004, Progenics is led by the distinguished medical geneticist Dr. Andrew Shuen, specializing in cancer genetics. Profits are reinvested into research and development, furthering the advancement of stem cell therapies in Canada.

Progenics Stem Cell Cryobank offers a compelling opportunity to secure the future of health by preserving the regenerative power of stem cells through cutting-edge technology and gene therapy.